| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,119 | 0.00 | 0 |
| 7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 17,857 | 0.00 | 0 |
| 29 Feb 24 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 14.56 | 35,000 | 509.60 k | 35,000 |
| 4 Jan 24 | SEELQ Seelos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.33 | 1,666 | 2.22 k | 1,666 |
| 6 Nov 23 | SKYE Skye Bioscience | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 14,110 | 49.39 k | 20,001 |
